About us


Forty51 Ventures is a Basel-based venture capital firm with its core strategy focused on company formation and early-stage investments in biotech with geographic emphasis on Switzerland, France and Germany. Forty51 Ventures leads and co-leads early financing rounds (Seed and Series A) of its growing portfolio which includes both academia and Pharma/Biotech spin-outs.